AZN - Prakiraan volume dodolan AstraZeneca

Leadership in developing targeted therapies and patent protection guarantee high margins for AstraZeneca PLC (AZN). The company relies on productive R&D research in the field of rare pathologies to ensure stable revenue growth. The company's expected trading volumes confirm business resilience, where the 99.33 mark reflects the current state. Global portfolio diversification effectively mitigates regulatory risks, providing reliable income protection.

AZN - Prakiraan volume dodolan AstraZeneca PLC ing rentang 04.07.2022 - 13.11.2026

Rincian metrik komprehensif lan analitis AstraZeneca Plc (AZN)

- nilai saham lan prakiraan konsensus rega:

Bagan rega AstraZeneca PLC|AZN - Prakiraan gabungan firma investasi

- statistik kapitalisasi pasar:

Kapitalisasi pasar AstraZeneca Plc|AZN - Nilai Perusahaan Nalika Diakuisisi Penuh

- informasi kapitalisasi buku:

Nilai Buku saben Saham AstraZeneca|AZN - Kapitalisasi Buku|Rasio Nilai Pasar marang Nilai Buku astrazeneca.com|AZN - Gunggung Aset Perusahaan

- data utang lan likuiditas:

Rasio Total Utang marang Ekuitas AstraZeneca PLC|AZN - Rasio silihan jangka dawa marang modal|Utang jangka cendhak marang ekuitas AstraZeneca AB|AZN - Kewajiban utang agregat|Utang-utang marang kapitalisasi buku AstraZeneca Plc|AZN - Utang jangka dawa perusahaan|Kewajiban jangka cendhak perusahaan AstraZeneca|Rasio cepet astrazeneca.com

- statistik bathi lan rasio pasar:

AZN - Penghasilan resik perusahaan|Bathi sing dikarepake AstraZeneca PLC|AZN - Pangali rega marang bathi|Pangali Forward P/E AstraZeneca|AZN - Rega marang bathi kanthi panyesuaian wutah|Pangali EV/EBITDA AstraZeneca Plc|AZN - Bathi operasional sadurunge ngurangi amortisasi|Bathi resik saben saham (EPS TTM) AstraZeneca|AZN - Bathi resik saben saham (EPS TTM)|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan astrazeneca.com|AZN - Tambahing bathi saben saham ing taun lumaku|Prakiraan wutah bathi resik saben saham kanggo taun ngarep AstraZeneca PLC

- indikator volume dodolan lan pendapatan:

AZN - Pendapatan tahunan perusahaan|Prakiraan pendapatan perusahaan AstraZeneca PLC|AZN - Rasio rega marang pendapatan|Multiplikator Forward P/S AstraZeneca Plc

Pambiji fundamental:AstraZeneca PLC

This indicator reflects market consensus expectations for future trading turnover, formed through the dynamics of opposing orders and quotes in the order book. By analyzing the company's planned sales volumes, investors assess the sustainability of AstraZeneca PLC (AZN) cash flows, where revenue security is underpinned by unique oncology patents and high barriers to entry that mitigate the pressure of government price regulation.

Analisis perusahaan pesaing

Prakiraan pendapatan perusahaan Eli Lilly and Company (LLY)|abbvie.com - Prakiraan pendapatan perusahaan|Prakiraan volume dodolan NVS (Novartis)|Prakiraan dodolan perusahaan Merck & Co.|Novo Nordisk Inc. - Prakiraan volume dodolan|AMGN - Prakiraan volume dodolan|Pfizer Inc. (PFE) - Prakiraan pendapatan perusahaan|SNY - Dodolan mangsa ngarep perusahaan|Volume dodolan mangsa ngarep perusahaan BMY|GSK (GSK Corp) - Prakiraan volume pendapatan perusahaan|Prakiraan pendapatan perusahaan Takeda Pharmaceutical Company Limited (TAK)|TEVA (Teva Pharmaceutical Industries Ltd.) - Pendapatan mangsa ngarep perusahaan|Prakiraan volume dodolan RDY (Dr. Reddy's Laboratories)|Prakiraan volume dodolan viatris.com VTRS|ROIV: Volume dodolan mangsa ngarep perusahaan|Pendapatan sing dikarepake perusahaan ZLAB|BHC: Prakiraan volume dodolan|Volume dodolan sing dikarepake perusahaan Cosmos Health Inc (COSM)